| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.002 |